PipelineHuidaGene has multiple R&D pipelines for ophthalmology and neurology.
-
01Neurology Diseases
MECP2 Duplication Syndrome (MDS)
Huntington's Disease (HD)
Amyotrophic Lateral Sclerosis (ALS)
-
02Ophthalmology Diseases
RPE65 Mutation-Associated Inherited Retinal Dystrophies (RPE65-IRD)
Neovascular Age-related Macular Degeneration (nAMD)
RHO-Associated Retinitis Pigmentosa (RHO-adRP)
-
03Neuromuscular Diseases
-
HuidaGene Selected for Presidential Symposium at ASGCT 2025 Annual Meeting, Showcasing 13 Abstracts Demonstrating Breakthroughs in Gene TherapyApr 18,2025
Learn More
-
HuidaGene at CRISPR MEDiCiNE 2025: A Celebration of Progress, Promise, and PatientsApr 11,2025
Learn More
-
HuidaGene Announces Broader Adoption of hfCas12Max Through Sublicensing Agreement to Advance Clinical Cell Therapy ProgramsApr 09,2025
Learn More